TRMB · XBRL financial data
Trimble financial statements, every quarter
The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (TRMB's year ends in early January)
| In millions of dollars | Sep 29, 2023 | Dec 29, 2023 | Mar 29, 2024 | Jun 28, 2024 | Sep 27, 2024 | Jan 3, 2025 | Apr 4, 2025 | Jul 4, 2025 | Oct 3, 2025 | Jan 2, 2026 | Apr 3, 2026 | Jul 3, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | year only | — | — | — | — | — | — | — | — | — | — |
| Revenue from contracts with customers | 957 | 932* | 953 | 871 | 876 | 983* | 841 | 876 | 901 | 970* | 940 | 972 |
| Cost of goods and services sold | 367 | 355* | 360 | 325 | 300 | 302* | 280 | 278 | 280 | 272* | 294 | 297 |
| Gross profit | 590 | 577* | 594 | 546 | 576 | 681* | 561 | 598 | 621 | 698* | 646 | 675 |
| Research and development | 163 | 168* | 170 | 162 | 156 | 175* | 159 | 163 | 153 | 156* | 170 | 177 |
| General and administrative | 117 | 118* | 134 | 149 | 128 | 138* | 122 | 118 | 118 | 127* | 127 | 150 |
| Total operating expenses | 469 | 480* | 484 | 484 | 459 | 508* | 463 | 470 | 471 | 482* | 502 | 543 |
| Operating income (loss) | 121 | 97* | 109 | 62 | 116 | 174* | 98 | 128 | 151 | 216* | 144 | 132 |
| Interest expense | 47 | 48* | 45 | 18 | 14 | 13* | 16 | 19 | 21 | 19* | 20 | 21 |
| Other income (expense) | (6) | 8* | (0) | 0 | (6) | 2* | 4 | 0 | (4) | (9)* | 6 | 4 |
| Income tax expense (benefit) | 5 | (4)* | 16 | 446 | 33 | 8* | 20 | 24 | 14 | 28* | 32 | 27 |
| Net income (loss) | 75 | 63* | 57 | 1,316 | 41 | 90* | 67 | 89 | 112 | 157* | 99 | (472) |
| Earnings per share, basic USD per share | 0.30 | 0.25* | 0.23 | 5.37 | 0.17 | 0.37* | 0.27 | 0.37 | 0.47 | 0.66* | 0.42 | (2.02) |
| Earnings per share, diluted USD per share | 0.30 | 0.25* | 0.23 | 5.34 | 0.16 | 0.36* | 0.27 | 0.37 | 0.46 | 0.65* | 0.42 | (2.02) |
| Weighted average shares, basic millions of shares | 249 | 248* | 246 | 245 | 246 | 246* | 243 | 238 | 238 | 237* | 235 | 233 |
| Weighted average shares, diluted millions of shares | 250 | 249* | 247 | 246 | 247 | 248* | 246 | 240 | 240 | 240* | 237 | 233 |
Balance sheet
CSVFiscal quarters (TRMB's year ends in early January)
Cash flows
CSVFiscal quarters (TRMB's year ends in early January)
| In millions of dollars | Sep 29, 2023 | Dec 29, 2023 | Mar 29, 2024 | Jun 28, 2024 | Sep 27, 2024 | Jan 3, 2025 | Apr 4, 2025 | Jul 4, 2025 | Oct 3, 2025 | Jan 2, 2026 | Apr 3, 2026 | Jul 3, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | 75 | 63* | 57 | 1,316 | 41 | 90* | 67 | 89 | 112 | 157* | 99 | (472) |
| Stock-based compensation | 39* | 33* | 36 | 37* | 37* | 48* | 38 | 38* | 35* | 35* | 42 | 43* |
| Depreciation and amortization | 69* | 65* | 63 | 63* | 53* | 53* | 49 | 50* | 51* | 51* | 50 | 51* |
| Net cash from operating activities | 147* | 99* | 234 | 88* | 95* | 115* | 156 | (54)* | 124* | 160* | 275 | 240* |
| Purchases of property and equipment | 13* | 10* | 7 | 14* | 6* | 6* | 7 | 6* | 7* | 6* | 6 | 7* |
| Net cash from investing activities | (14)* | (4)* | (4) | 1,875* | (11)* | 1* | (15) | (13)* | (9)* | (1)* | (5) | (240)* |
| Proceeds from issuing common stock | 18* | (1)* | 12 | (34)* | 16* | (1)* | 16 | (39)* | 24* | (1)* | 17 | (49)* |
| Share repurchases | 0* | 100* | 175 | 0* | 0* | 0* | 627 | 50* | 50* | 136* | 323 | 6* |
| Repayments of long-term debt | 524* | 436* | 556 | 1,244* | 0* | 400* | 115 | 113* | 350* | 0* | 147 | 583* |
| Net cash from financing activities | (141)* | (89)* | (202) | (1,278)* | 16* | (401)* | (611) | 29* | (147)* | (139)* | (286) | (17)* |
| Net change in cash | (14)* | 16* | 23 | 683* | 110* | (306)* | (458) | (24)* | (33)* | 21* | (19) | (20)* |
Compare with peers
SIC 3829 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3829 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| Trimble | 214 | 972 | 240* | 233.2M | 10-QJul 3, 2026 |
| Fortive | 377 | 1,108 | 313* | 297.6M | 10-QOct 2, 2026 |
| Keysight Technologies | 2,605 | 1,846 | 437* | 170.2M | 10-QJul 31, 2026 |
| Waters | 539 | 1,645 | 201* | 98.2M | 10-QJul 4, 2026 |
| Mettler Toledo International | 51 | 1,027 | 310* | 20.0M | 10-QJun 30, 2026 |
| Veralto | 1,785 | 1,509 | 323* | 243.1M | 10-QOct 2, 2026 |
| Agilent Technologies | 1,758 | 1,878 | 519* | 281.9M | 10-QJul 31, 2026 |
| Teradyne | 461 | 1,306 | 314* | 156.1M | 10-QSep 27, 2026 |
| Bio-Rad Laboratories | 517 | 651 | 99* | not reported | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.